Trial Profile
A Multicenter, Open Label Study to Evaluate the Adrenal Suppression Potential of Mapracorat 0.1% Ointment in Adults With Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2023
Price :
$35
*
At a glance
- Drugs Mapracorat (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Bayer
- 23 Dec 2014 New trial record